Sort
23,748 grants matching “melanoma”
Pathology Core
$426,198Xiaowei Xu · Wistar Institute · P01 · FY2021 · CA
The Role of Schwann Cells in the Progression of Melanoma
$426,170Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Histone Arginine Demethylation through Cleavage
$426,167Gongyi Zhang · National Jewish Health · R01 · FY2023 · GM
Molecular Epidemiology of Non-Melanoma Skin Cancer
$426,115Heather Nelson · Harvard School Of Public Health · R01 · FY2006 · CA
Effect of the plantar skin microenvironment on tumor metastasis and drug tolerance
$426,082Vito William Rebecca · Johns Hopkins University · R01 · FY2024 · CA
Effect of the plantar skin microenvironment on tumor metastasis and drug tolerance
$426,082Vito William Rebecca · Johns Hopkins University · R01 · FY2025 · CA
Murine & Human In Vivo Models of Melanoma Formation
$426,041Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · P01 · FY2011 · ES
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$425,938Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2020 · NS
How Circulating Melanoma Cells Usurp the Leukocyte Transmigration Mechanism for Successful Metastasis
$425,919William A Muller · Northwestern University At Chicago · R01 · FY2020 · CA
How Circulating Melanoma Cells Usurp the Leukocyte Transmigration Mechanism for Successful Metastasis
$425,919William A Muller · Northwestern University At Chicago · R01 · FY2021 · CA
How Circulating Melanoma Cells Usurp the Leukocyte Transmigration Mechanism for Successful Metastasis
$425,919William A Muller · Northwestern University At Chicago · R01 · FY2019 · CA
Developmental therapy for selectively targeting MEK-ERK pathway in cancer cells and tumor stromal compartment
$425,913Shihui Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
An In Situ Patient-specific Chemo-Immunotherapy for Skin Cancers
$425,907Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · CA
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ
$425,863David J Mooney · Harvard University · R01 · FY2021 · CA
Measuring nucleotide excision repair in human populations
$425,770Laura Jane Niedernhofer · University Of Minnesota · U01 · FY2021 · ES
Research Project 2: Development of Synergetic EKR Combinations in PDAC
$425,714Andrea Wang-Gillam · Washington University · U54 · FY2017 · CA
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
$425,512Qing Yi · Methodist Hospital Research Institute · R01 · FY2019 · CA
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
$425,512Qing Yi · Methodist Hospital Research Institute · R01 · FY2020 · CA
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
$425,512Qing Yi · Methodist Hospital Research Institute · R01 · FY2021 · CA
Southwest Oncology Group
$425,510Patrick J Stiff · Loyola University Chicago · U10 · FY2007 · CA
Synergistic Targeting of the MAP Kinase Pathway in Melanoma
$425,498Ronen Marmorstein · Wistar Institute · P01 · FY2013 · CA
PTEN Nuclear-Cytoplasmic Localization in Breast Cancer
$425,494Charis Eng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2011 · CA
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$425,436Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Dual-pronged nano-drug delivery using plant virus-like particles.
$425,350Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2020 · CA
THE ROLE OF GSDME IN MELANOMA BRAIN METASTASES
$425,322Drexel University · · FY2021 · Defense Health Agency